- Home
- SNES vs ATNF Comparison
SNES vs ATNF Comparison
Compare SNES & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- ATNF
- Stock Information
- Founded
- SNES 2004
- ATNF 2016
- Country
- SNES United States
- ATNF United States
- Employees
- SNES N/A
- ATNF N/A
- Industry
- SNES Agricultural Chemicals
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- SNES Industrials
- ATNF Health Care
- Exchange
- SNES Nasdaq
- ATNF Nasdaq
- Market Cap
- SNES 2.3M
- ATNF 2.6M
- IPO Year
- SNES 2016
- ATNF N/A
- Fundamental
- Price
- SNES $3.16
- ATNF $1.74
- Analyst Decision
- SNES Strong Buy
- ATNF
- Analyst Count
- SNES 1
- ATNF 0
- Target Price
- SNES $10.00
- ATNF N/A
- AVG Volume (30 Days)
- SNES 311.7K
- ATNF 128.8K
- Earning Date
- SNES 11-12-2024
- ATNF 02-13-2025
- Dividend Yield
- SNES N/A
- ATNF N/A
- EPS Growth
- SNES N/A
- ATNF N/A
- EPS
- SNES N/A
- ATNF N/A
- Revenue
- SNES $1,651,000.00
- ATNF N/A
- Revenue This Year
- SNES $91.45
- ATNF N/A
- Revenue Next Year
- SNES $101.31
- ATNF $54.15
- P/E Ratio
- SNES N/A
- ATNF N/A
- Revenue Growth
- SNES 38.16
- ATNF N/A
- 52 Week Low
- SNES $1.90
- ATNF $1.16
- 52 Week High
- SNES $21.40
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- SNES 56.47
- ATNF 32.45
- Support Level
- SNES $2.32
- ATNF $1.69
- Resistance Level
- SNES $5.00
- ATNF $2.26
- Average True Range (ATR)
- SNES 0.52
- ATNF 0.19
- MACD
- SNES 0.13
- ATNF -0.02
- Stochastic Oscillator
- SNES 35.66
- ATNF 4.61
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.